Page 4 - Ellume Limited News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ellume limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ellume Limited Today - Breaking & Trending Today

KUOW - U.S. Cuts $231 Million Deal To Provide 15-Minute COVID-19 At-Home Tests


U.S. Cuts $231 Million Deal To Provide 15-Minute COVID-19 At-Home Tests
at
9:51 am
NPR
The Biden administration has made a $231.8 million deal with an Australian company to boost availability of the first at-home rapid test for the coronavirus, which causes COVID-19 that is available without a prescription. The test, made by Ellume, can send results to a smartphone within 15 minutes of receiving a sample.
The Food and Drug Administration gave emergency authorization to Ellume s rapid test in December, after it showed 96% accuracy in a U.S. clinical study. Those trials included both adults and children of ages 2 years and older. ....

White House , District Of Columbia , United States , Andy Slavitt , Johns Hopkins University , Response Team , Drug Administration , Us Defense Department , Ellume Limited , Deal To Provide , Health Rapid Acceleration , Johns Hopkins , வெள்ளை வீடு , மாவட்டம் ஆஃப் கொலம்பியா , ஒன்றுபட்டது மாநிலங்களில் , ஜான்ஸ் ஹாப்கின்ஸ் பல்கலைக்கழகம் , பதில் அணி , எங்களுக்கு பாதுகாப்பு துறை , ஒப்பந்தம் க்கு வழங்க , ஆரோக்கியம் விரைவான விரைவுபடுத்துதல் , ஜான்ஸ் ஹாப்கின்ஸ் ,

U.S. Cuts $231 Million Deal To Provide 15-Minute COVID-19 At-Home Tests


Ellume Limited
toggle caption
Ellume Limited
Ellume, an Australian company, manufactures a 15-minute at-home test for the coronavirus, which causes COVID-19.
Ellume Limited
Updated 5:30 p.m. ET
The Biden administration has made a $231.8 million deal with an Australian company to boost availability of the first at-home rapid test for the coronavirus which causes COVID-19 that is available without a prescription. The test, made by Ellume, can send results to a smartphone within 15 minutes of receiving a sample.
The Food and Drug Administration gave emergency authorization to Ellume s rapid test in December, after it showed 96% accuracy in a U.S. clinical study. Those trials included both adults and children of ages 2 years and older. ....

White House , District Of Columbia , United States , Andy Slavitt , Response Team , Drug Administration , Ellume Limited , Health Rapid Acceleration , வெள்ளை வீடு , மாவட்டம் ஆஃப் கொலம்பியா , ஒன்றுபட்டது மாநிலங்களில் , பதில் அணி , ஆரோக்கியம் விரைவான விரைவுபடுத்துதல் ,

FDA Nod For Abbott's At-home Covid-19 Test


FDA Nod For Abbott s At-home Covid-19 Test
NORTH CHICAGO (dpa-AFX) - The U.S. Food and Drug Administration has issued a new emergency use authorization or EUA for Abbot Diagnostics Covid-19 home test.
The BinaxNOW COVID-19 Ag Card Home Test is now authorized for prescription use at home with self-collected nasal swab samples from individuals ages 15 years or older who are suspected of COVID-19 by their healthcare provider.
The test is also authorized for use with adult-collected nasal swab samples from individuals ages four years or older who are suspected of COVID-19 by their healthcare provider.
In both instances, the test can be conducted within the first seven days of symptom onset. ....

Jeff Shuren , Abbott Binax , Radiological Health , Drug Administration , Abbot Diagnostic , Card Home Test , Ellume Limited , கதிரியக்கவியல் ஆரோக்கியம் , திருமட முதல்வர் கண்டறியும் , அட்டை வீடு சோதனை ,